Drug and Anti-Viral Peptide Design to Inhibit the Monkeypox Virus by Restricting A36R Protein

Most recently, monkeypox virus (MPXV) has emanated as a global public health threat. Unavailability of effective medicament against MPXV escalates demand for new therapeutic agent. In this study, in silico strategies were conducted to identify novel drug against the A36R protein of MPXV. The A36R pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Miah, Mohammad Mohasin, Tabassum, Nuzhat, Afroj Zinnia, Maliha, Islam, Abul Bashar Mir Md. Khademul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772960/
https://www.ncbi.nlm.nih.gov/pubmed/36570327
http://dx.doi.org/10.1177/11779322221141164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772960/
https://www.ncbi.nlm.nih.gov/pubmed/36570327
http://dx.doi.org/10.1177/11779322221141164

Ejemplares similares